Tv. Achenbach et al., Inhibition of cyclin-dependent kinase activity and induction of apoptosis by preussin in human tumor cells, ANTIM AG CH, 44(10), 2000, pp. 2794-2801
In this paper, we report that (+)-preussin, a pyrrolidinol alkaloid origina
lly identified as an antifungal agent, has growth-inhibitory and cytotoxic
effects on human cancer cells. Preussin was found to be a potent inhibitor
of cyclin E kinase (CDK2-cyclin E) in vitro (50% inhibitory concentration;
similar to 500 nM) and to inhibit cell cycle progression into S phase. In a
greement with these findings, the level of the cyclin-dependent kinase inhi
bitor p27(KIP-1) is increased in response to preussin treatment while the e
xpression of both cyclin A and the transcription factor E2F-1 is down-regul
ated. Preussin also induces programmed cell death (apoptosis), which requir
es caspase activation and involves the release of cytochrome c from mitocho
ndria. This induction of apoptosis is not blocked by high levels of Bcl-2,
which usually confers resistance to chemotherapeutic agents. Taken together
, our data indicate that preussin could be a promising lead compound for th
e development of a new class of potent antitumor drugs.